Fideicomiso Irrevocable F/2061 FHipo
BNZIF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.39 | 0.01 | -0.44 | 0.53 |
| FCF Yield | 14.53% | 286.25% | 5.59% | -9.43% |
| EV / EBITDA | 31.00 | 14.04 | 0.00 | 24.40 |
| Quality | ||||
| ROIC | 1.28% | 0.64% | -3.00% | 2.25% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 99.77% |
| Cash Conversion Ratio | 10.62 | 10.94 | 8.37 | -2.41 |
| Growth | ||||
| Revenue 3-Year CAGR | -14.07% | -13.04% | 2.59% | 23.64% |
| Free Cash Flow Growth | -47.72% | 150.02% | 196.20% | -177.80% |
| Safety | ||||
| Net Debt / EBITDA | 13.40 | 12.56 | 0.00 | 11.18 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 5,178.03 | 6,048.84 | 2,033.01 | 1,010.88 |